X-group (possible homology)

1107 Pilin

Ligands and drugs

408
Member domains
390
with ligand contacts (≤ 4 Å)
95.6% of members
336
with DrugDomain annotations
82.4% of members
121
with a DrugBank compound
29.7% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

3
Proteins with classified ligands
2
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Lipids and lipid-like molecules20.36.07×not tested
Organic acids and derivatives10.52.19×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB02043LHG1,2-Dipalmitoyl-Phosphatidyl-Glycerole121

Most frequently bound compounds

PDB ligandNameDomains in contact
LHG1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE174
6V6[(2~{S})-3-[[(2~{R})-2,3-bis(oxidanyl)propoxy]-oxidanyl-phosphoryl]oxy-2-hexadec-9-enoyloxy-propyl] hexadecanoate145
KSV(2R)-2,3-dihydroxypropyl ethyl hydrogen (S)-phosphate70
X411-MYRISTOYL-2-MYRISTOLEOYL-SN-GLYCERO-3-PHOSPHATE1